Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disease with multisystem complications including neurodegeneration, hepatosplenomegaly, interstitial lung disease (ILD), bone marrow disease, and growth failure.
Drew B. Sinha +7 more
doaj +1 more source
Screening for acid sphingomyelinase deficiency in patients with an interstitial lung disease. [PDF]
Vermant M +12 more
europepmc +1 more source
Improvement in quality of life and general functions in pediatric acid sphingomyelinase deficiency patients after receiving olipudase alfa: A single-center experience in Taiwan. [PDF]
Pan YW, Yu WH, Tsai MC, Chou YY.
europepmc +1 more source
Adults With Acid Sphingomyelinase Deficiency Have Sustained Improvements in Clinical Outcomes With up to 5 Years of Olipudase Alfa Enzyme Replacement Therapy: ASCEND Trial Final Results. [PDF]
Wasserstein MP +20 more
europepmc +1 more source
Acid Sphingomyelinase Activity in Dried Blood Spot from Neonatal Intensive Care Unit-Admitted Neonates: A Pilot Study for Expanded Newborn Screening in Japan. [PDF]
Kato A +7 more
europepmc +1 more source
Impact of Diffusing Lung Capacity for Carbon Monoxide on Mortality Risk in Patients with ASMD: Insights from a Post Hoc Analysis. [PDF]
Wuyts WA +7 more
europepmc +1 more source
The Role of Metal Complexation in the Unfolding Energetics of a Nudix Hydrolase. [PDF]
Alt N, Zhuang Y, Quirk S, Hernandez R.
europepmc +1 more source
A Retrospective Chart Review Study on the Burden of Illness of Acid Sphingomyelinase Deficiency in Brazil. [PDF]
Giugliani R +13 more
europepmc +1 more source
Olipudase alfa IgE-mediated anaphylaxis prevented by omalizumab and tailored desensitization in a child with acid sphingomyelinase deficiency. [PDF]
Fiori L +6 more
europepmc +1 more source

